PHARMACEUTICAL ASSISTANCE PROGRAMS
|
|
|
- Stanley Robinson
- 10 years ago
- Views:
Transcription
1 CHAPTER 23 PHARMACEUTICAL ASSISTANCE PROGRAMS Many pharmaceutical companies provide prescription medicines free of charge to consumers and to physicians whose patients might not otherwise have access to necessary medicines. Each of the special programs offered by the pharmaceutical companies has its own set of eligibility criteria and specific instructions about making a request for assistance. In many cases, your physician is required to refer you to the pharmaceutical assistance program or to make an application on your behalf. Most of these programs have strict eligibility requirements. Many require that a patient have no health coverage (including Medicaid or Medigap insurance). Some companies use income limits to ascertain eligibility. This guide lists some of the drugs available from the different companies. Other drugs may also be available. Talk with your pharmacist or physician to find out which company makes the drug you need. These programs may change at any time. Other programs may also be available. If you need assistance, talk to your doctor. He or she may be able to ask local sales representatives about other programs. In addition, the Pharmaceutical Research and Manufacturers of America (PhRMA) maintains a list of companies with patient assistance programs. Visit the organization s Web site at for additional information. The following section provides information about the pharmaceutical assistance programs offered by various drug manufacturers. They are listed in alphabetical order by manufacturer. Abbott Laboratories (800) Product: Most Abbott Laboratories products. Physicians should call for application information. 168
2 Agouron Agouron (888) Products: Viracept and Rescriptor The applicant or physician may contact the program. Applications are mailed to the physician. Eligibility is determined on a case-by-case basis. Alcon Labs Glaucoma Assistance Program (800) Products: Glaucoma medications only Ophthalmologists must call on behalf of the patient. Medical Needs Program (800) , Ext #3 Products: All non-glaucoma products The physician must write a letter on the patient s behalf. Allergan, Inc. Allergan (800) Products: Alphagan, Betagen, Celluvisc, Propine, Pilagan, Epifrin, Lacri- Lube, Refresh, Refresh Plus, Refresh PM, Tears Plus The physician must send a special request letter on behalf of the patient. Alza Indigent (800) Products: BiCitra, Concerta, Ditropan, Elmiron, Mycelex, Neutro-Phos, PolyCitra, Testoderm, Ocusert, Progestasert The physician must request an Indigent Patient Application Kit. Amarin Indigent Patient Program (908) Products: Bontril, Capital and Codein oral suspension, Exgest, Hydrocet, Motofen, Nolahist, Nolamine, Phrenilin, Phrenilin Forte, Salflex The physician must call and complete the application. The patient's income must be below the federal poverty guidelines and the patient may not have any other assistance. 169 Chapter 23 Pharmaceutical Assistance Programs
3 Amgen, Inc. Safety Net Programs for Epogen (800) Products: Epogen For dialysis patients only. Providers apply on behalf of their patients. Safety Net Program for Infergen (888) Products: Infergen For Chronic Hepatitis C patients only. Providers apply on their patients behalf. Safety Net Program for Neupogen (800) Products: Neupogen Providers should call for an application. AstraZeneca AstraZeneca LP (800) Products: Atacand, Emla, Lexxel, Plendil, Prilosec, Tonocard, Toprol The physician must apply on behalf of the patient. Foscavir Assistance and Information on Reimbursement State and Federal Associates (800) 488-FAIR (3247) Product: Foscavir The physician must make referral. AstraZeneca Foundation (800) Products: Many AstraZeneca products The patient may call for application information. Eligibility is determined on a case-by-case basis. Aventis Pasteur Indigent Patient Program (800) VACCINE, (800) Products: Imovax and Imogam rabies vaccine Eligibility is determined on a case-by-case basis. PART V: Health Care Provided Free or at Reduced Rates 170
4 Aventis Aventis (800) Product: Many Aventis products Patients must have income below the federal poverty guidelines and not have any other coverage. The patient or physician may contact the company. Bayer Corporation Pharmaceutical Division Bayer Indigent Patient Program (800) , Ext. 2765; (800) Products: Most Bayer prescription products The physician or patient can call to determine eligibility. Patients who are eligible for government programs or covered by insurance are not eligible for this program. Berlex Laboratories Berlex Laboratories (800) Products: Betapace, Quinaglute Dura-Tabs The enrollment form must be completed by the physician. Oncology CamCare (800) Product: Campath Fludara A short qualification form must be completed by the physician. Biogen, Inc. Avonex Access Program (800) Product: Avonex Eligibility is determined based on insurance status and income. The physician should call for information. Boehringer Ingleheim (800) Products: Aggrenox, Atrovent, Cafcit, Catapres, Combivent, Flomax, Micardis, Mobic, and Viramune Eligibility is determined on a case-by-case basis. Patients who qualify for Medicaid or have other drug coverage are not eligible. 171 Chapter 23 Pharmaceutical Assistance Programs
5 Bristol-Myers Squibb Company (800) Products: Many Bristol-Myers Squibb pharmaceutical products Physicians or other providers should call the toll-free number above to request an application form. Centocor, Inc. Remicade (800) Product: Remicade The patient or physician may submit an application. The patient must meet financial qualifications. Centocor Solutions Program for Retavase (800) Product: Retavase The patient must meet financial criteria. The provider should contact the company and complete an application. Ciba DuPont Company See Novartis (800) Products: Most non-controlled prescription products The physician should contact the company for application information. Eligibility is based on income and insurance status. Eisai Inc. Aricept (800) Product: Aricept The patient may not have insurance coverage for medications and must also meet income criteria. Aciphex (800) Product: Aciphex The patient must meet certain financial criteria. Physicians should call for information. PART V: Health Care Provided Free or at Reduced Rates 172
6 Elan Elan Prescription Assistance Program (800) (Patients) (800) (Physicians and staff only) Products: Permax, Zanaflex, Diastat, Mysoline, Zonegran Patients must meet income criteria and have no third-party coverage. Fujisawa Healthcare Prograf (800) 4-PROGRAF, (800) Product: Prograf Patients must have no insurance coverage for medications and must meet financial eligibility criteria. Physicians should call for information. Genentech, Inc. Genentech Assistance Program (800) Products: Activase, Herceptin, Protropin, Nutropin, Rituxin, and TNKase The physician should contact the program. A completed application form including medical, financial, and insurance information must be submitted for consideration. The patient cannot be eligible for other assistance. Genentech Endowment for Cystic Fibrosis (704) Product: Pulmozyme Three programs can help patients who are uninsured, or can help with the out-of-pocket costs for patients who do have insurance. Assistance is based on a sliding scale. Physicians should contact the company for more information. Genetics Institute The Benefix Reimbursement and Information Program (888) Product: Benefix Coagulation Factor IX The patient must meet certain financial criteria. An application must be completed by the physician and patient. Neumega Access Program (888) NEUMEGA ( ) Product: Neumega This program is for patients who meet financial eligibility criteria and are uninsured or underinsured. The physician or patient may call for information. 173 Chapter 23 Pharmaceutical Assistance Programs
7 Genzyme Corporation Ceredase/Cerezyme Access Program (800) , Ext Products: Ceredase, Cerezyme Eligibility is based on financial need. The patient cannot have other coverage. Gilead Sciences, Inc.Gilead Sciences Reimbursement Support and Assistance Program (800) Products: Daunoxome, Vistide The program can assist both uninsured and insured patients with reimbursement. GlaxoSmithKline Glaxo Wellcome (800) Products: All current Glaxo Wellcome products for outpatient use. Eligibility is based on information provided by a physician or advocate regarding the patient s prescription drug coverage and financial resources. SmithKline Beecham Foundation Access to Care (800) , (800) Products: Amoxil, Augmentin, Avandia, Bactroban, Compazine, Coreg, Dyazide, Famvir, Paxil, Relafen, Requip, and Tagamet The patient must meet financial criteria. Assistance may also be available for co-payments for insured patients. The patient and physician must complete the application. Oncology Access to Care Program (800) Product: Hycamtin The patient or physician should call for more information about this program. Hoechst Marion Roussel Immunex Corporation See Aventis (800) Products: Leukine, Novantrone, Amicar, Thioplex PART V: Health Care Provided Free or at Reduced Rates 174
8 The physician should apply on the patient s behalf. Eligibility is based on the patient's income and insurance status. The patient cannot be eligible for other assistance. Janssen Pharmaceutica (800) (800) for Aciphex Products: All Janssen prescription products Patients must meet certain medical and financial criteria. Aciphex See Eisai, Inc. The Risperdal and the Risperdal Reimbursement Support Program (800) Eligibility is determined by financial criteria. The program also provides support obtaining insurance reimbursement. Knoll Pharmaceutical Company Indigent Patient Program (800) Products: Mavik, Rythmol, Synthroid, Tarka Physicians should call the toll-free number above and request an evaluation form. Decisions are made on a case-by-case basis. Lederle Laboratiories Eli Lilly and Company See Wyeth-Ayerst Laboratories Lilly Cares (800) Products: Almost all prescription products; no controlled substances Patient eligibility is determined on a case-by-case basis in consultation with the prescribing physician. Applications are given to physicians. 175 Chapter 23 Pharmaceutical Assistance Programs
9 Gemzar (888) 4-GEMZAR ( ) Product: Gemzar Patients must meet financial criteria and have exhausted all other sources of assistance. The Liposome Company Financial Assistance Program for Abelcet (800) Product: Abelcet The physician should call to enroll the patient. The patient must meet financial eligibility criteria and have no other source of reimbursement. Merck and Co., Inc. (800) Products: Most Merck products The physician should call the toll-free number above for an enrollment form. The application must be completed by the physician and patient. Eligibility is determined on a case-by-case basis. for Aggrastat Product: Aggrastat Patients must meet financial eligibility criteria and have no other source of reimbursement. The program can also assist in gaining reimbursement from insurance. The physician or patient may call for information. The Support Program for Crixivan (800) Product: Crixivan The program can assist patients in finding a payment source and may provide medication for those who meet financial criteria. The physician or patient may call for more information. Novartis (800) Product: Certain single-source or life-sustaining products; no controlled substances The physician and patient must complete an application. Eligibility is determined on a case-by-case basis. PART V: Health Care Provided Free or at Reduced Rates 176
10 Organon, Inc. Remeron Indigent Patient Program Product: Remeron The physician should direct a request for assistance to a local sales representative. Gold Star Fertility Assistance Program Product: Follistim Eligibility is determined on a case-by-case basis. The physician should direct a request to a local sales representative. Ortho Biotech Inc. Procritline (800) Products: Procrit (for non-dialysis use), Leustatin Injection Call the toll-free number above; this call can help determine if a patient meets medical and financial criteria. Ortho Dermatological Products: Prescription products Patients can have no insurance coverage for medications and must have incomes below the federal poverty guidelines. The physician should request an application form. Ortho-McNeil Pharmaceutical, Inc.Patient Assistance program (800) Product: Most prescription products The physician should request an application. The patient can have no other source of reimbursement and must have income below the federal poverty guidelines. Otsuka America Pharmaceutical, Inc.RxMAP Prescription Medication Assistance Program (800) Product: Pletal Eligibility is based on the federal poverty guidelines and lack of other coverage. The physician should call for more information. Parke-Davis See Pfizer 177 Chapter 23 Pharmaceutical Assistance Programs
11 Pfizer Inc. Pfizer Prescription Assistance (800) Products: Most outpatient products While special application forms are not required, the physician must write a letter on the patient s behalf. Parke-Davis (908) Products: Accupril, Accuretic, Dilantin, Estrostep, FemHRT, Lipitor, Loestrin, Neurontin, Zarontin The physician should request an application from a local sales representative. The patient must have no other source of reimbursement. Sharing the Care (800) Products: Certain single-source products The program operates through community, migrant, and homeless health centers. Only patients at these clinics are eligible. Diflucan and Zithromax (800) Products: Diflucan and Zithromax The physician should call for enrollment information. The patient must meet income eligibility criteria and may not have insurance or other assistance. Pharmacia Corporation (800) Products: Many products The patient or physician may initiate a request for assistance by calling the toll-free number above. An application form must be completed by the physician and patient. Patients in Need (800) Products: Aldactazide, Aldactone, Calan SR, Kerlone, Calan, Covera-HS, Norpace, Norpace CR, Arthrotec, Celebrex, Cytotec The physician determines patient eligibility based on medical and financial guidelines. The physician should contact a local Searle representative or call on the patient s behalf. PART V: Health Care Provided Free or at Reduced Rates 178
12 Proctor & Gamble, Inc. Customer Services (800) Products: Actonel, Asacol, Dantrium capsules, Didronel, Macrodantin, Macrobid The physician and patient must complete an application form. Eligibility is determined on a case-by-case basis. Rhone-Poulenc Rorer, Inc. See Aventis Roche Laboratories Medical Needs Program (800) Products: Most products The physician must request an application form. The patient may not have insurance coverage or other assistance. Medical Needs Program for CellCept, Cytovene, and Cytovene-IV (800) Products: CellCept, Cytovene, Cytovene-IV The physician should call for information. Medical Needs Program for Fortovase, Invirase, Cytovene, Cytovene-IV, and Hivid (800) Products: Fortovase, Invirase, Cytovene, Cytovene-IV, Hivid For HIV patients. The physician should call for more information. Medical Needs Program for Kytril, Roferon-A, Vesanoid, Xeloda, and Fluorouracil Injection (800) (press 2 or 3) Products: Kytril, Roferon-A, Vesanoid, Xeloda, Fluorouracil Injection The physician should call for information. Roxane Laboratories, Inc. (800) Products: Oramorph SR, Roxanol, Roxanol 100, Roxicodone Physicians must call the program to discuss their patients eligibility. If the patient appears to meet insurance and financial eligibility, an application form will be mailed to the physician. 179 Chapter 23 Pharmaceutical Assistance Programs
13 Sandoz Pharmaceutical Corporation Sankyo Pharma See Novartis Open Care Program (866) Product: WelChol The physician must apply on a patient s behalf. Patients must have no source of reimbursement. The program can help obtain insurance reimbursement for insured patients. Sanofi-Synthelabo, Inc. Needy Patient Program (800) Products: Several products, including Aralen, Danocrine, Primaquine The physician should call the toll-free number or the local Sanofi Winthrop representative. Eligibility is determined on a case-by-case basis. Schering Laboratories/ Key Commitment to Care For Intron A/Eulexin: (800) For other products: (800) Products: Most prescription products Patient eligibility is determined on a case-by-case basis. An application form must be completed by the physician and patient. Searle Serono, Inc. See Pharmacia Connections for Growth (800) Product: Saizen A referral must be made by the physician. SeroCare (800) Product: Serostim The physician should call for more information. PART V: Health Care Provided Free or at Reduced Rates 180
14 Sigma-Tau, Inc. NORD/Sigma-Tau Carnitor Drug Assistance Program (800) 999-NORD Product: Carnitor SmithKline Beecham See GlaxoSmithKline The patient must demonstrate financial need beyond any available reimbursement. The patient may call and submit an application. NORD/Sigma-Tau Matulane (800) 999-NORD Product: Carnitor The patient must show financial need and the physician must feel a treatment response is possible. The patient may call for information. Solvay / Unimed (800) Products: Aceon, Creon Minimicrospheres, Estratab, Estratest, Estratest HS, Lithobid, Rowasa, Anadrol, Marinol, Teveten The patient must meet financial eligibility criteria. The physician must call for an application form. 3M Indigent Patient Pharmaceutical Program (800) Products: Most products Patients are considered on a case-by-case basis, based on financial need and insurance status. The physician should call for more information. Takeda America (877) TAKEDA or Product: Actos The patient must meet financial eligibility criteria and have no other source of reimbursement. An application is sent to the physician. Unimed See Solvay 181 Chapter 23 Pharmaceutical Assistance Programs
15 Wyeth-Ayerst Laboratories Norplant Foundation (703) Product: Norplant five-year contraceptive system Eligibility is determined on a case-by-case basis. The physician should call for more information. Rheumatoid Arthritis Assistance Foundation (800) Product: Enbrel The patient or physician should call to determine eligibility. Write to: John E. James Professional Services IPP 555 E. Lancaster Avenue St. Davids, PA Products: Various products The physician must identify a patient as indigent, defined as having low or no income and not covered by any third party. A limited supply of the requested medication is provided to the physician for dispensing to the patient. Zeneca See AstraZeneca PART V: Health Care Provided Free or at Reduced Rates 182
Directory. Programs. Patient Assistance. Prescription Drug
Directory of Prescription Drug Patient Assistance Programs 1999 2000 INTRODUCTION The research-based pharmaceutical industry has had a long-standing tradition of providing prescription medicines free of
CHEM-E4140 Selectivity 12. Pharma Business
CHEM-E4140 Selectivity 12. Pharma Business Prof. Ari Koskinen Laboratory of Organic Chemistry C318 Pharma Business Total volume ca 1100 G$ (Shell 421G$; Walmart 486G$; Toyota 252 G$). Annually approx 25
Curriculum Vitue. Janet Raffa Curtis, ARNP, CS, MSN. Sub Investigator, Clinical Research Division
Curriculum Vitue Janet Raffa Curtis, ARNP, CS, MSN Sub Investigator, Clinical Research Division Office: Education: Advanced Dermatology & Cosmetic Surgery 120 international Pkwy., suite 240 Heathrow FL,
Commercial Insight Osteoarthritis and Rheumatoid Arthritis
A Datamonitor In-Depth Analysis Commercial Insight Osteoarthritis and Rheumatoid Arthritis New Growth In A Mature Market Published: Jul-03 Product Code: DMHC1891 Why buy this analysis? Target current and
CO-PAY PROGRAMS FOR HIV and Hepatitis
CO-PAY PROGRAMS FOR HIV and Hepatitis CO-PAY PROGRAMS FOR HIV These programs offer assistance to people with private health insurance for the co-payments they have to make at the pharmacy for their HIV
Buying Process and Negociation. from a Group of Pharmacies Point of View
Buying Process and Negociation from a Group of Pharmacies Point of View Agenda: Demographics Sector Analysis Trends Pharmaceutical Market Overview Pharmaceutical Retails Market Overview The Future Business
Guide. Astellas Pharma US, Inc. XTANDI Access Services SM 2015 NCCN Virtual Reimbursement Resource Room. NCCN.org/reimbursement
Astellas Pharma US, Inc. XTANDI Access Services SM 2015 NCCN Virtual Reimbursement Resource Room Guide The oncology reimbursement landscape continues to present ever-evolving challenges for clinicians
Top 25 Largest Whistleblower Rewards paid under the False Claims Act and Qui Tam Whistleblower Reward Program
Top 25 Largest Whistleblower Rewards paid under the False Claims Act and Qui Tam Whistleblower Reward Program Here is a list of the top 25 largest Federal and State False Claims Act qui tam whistleblower
The Basics of Pharmacy Benefits Management (PBM) 2009
The Basics of Pharmacy Benefits Management (PBM) 2009 Andrew Kingery Pharmacy Account Management Virginia CE Forum 2009 Course# 201719 Objectives & Introduction Provide basic components of a PBM Define
Outcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct
Outcomes of Monitoring Committee Reviews Medicines Australia Code of Conduct 1 Medicines Australia ABN 23 126 990 001 Level 1, 16 Napier Close Deakin ACT 2600 Phone: 02 6122 8500 Fax: 02 6122 8555 Web:
It s In The Cards: Pharmaceutical Co-pay and Patient Assistance Programs. Jeff Berry Editor, Positively Aware
It s In The Cards: Pharmaceutical Co-pay and Patient Assistance Programs Jeff Berry Editor, Positively Aware PAPs, Co-Pays, and ADAPs, Oh My! Patient Assistance Programs (PAPs) provide free or low-cost
Stakeholder Insight: Rheumatoid arthritis - Rising competition by line and severity
Brochure More information from http://www.researchandmarkets.com/reports/1383065/ Stakeholder Insight: Rheumatoid arthritis - Rising competition by line and severity Description: Introduction Disease-modifying
INCENTIVE COMPENSATION CONFERENCE
Announcing the 2nd Annual ZS Associates INCENTIVE COMPENSATION CONFERENCE 08 September 23 24, 2008 Philadelphia, PA Incentive compensation greatly affects sales force motivation and morale. When designed
Stakeholder Perspectives: Mild Cognitive Impairment and Dementia
A Datamonitor In-Depth Analysis Stakeholder Perspectives: Mild Cognitive Impairment and Dementia Aricept in Race to Pioneer Unexplored Markets Published: Aug-03 Product Code: DMHC1924 Why buy this analysis?
Commercial Perspectives: Multiple Sclerosis
A Datamonitor Report Commercial Perspectives: Multiple Sclerosis How to Find Opportunities in an Unremitting Market Published: Jun-04 Product Code: Providing you with: In-depth profiles of current market-leading
Patient Assistance Programs
Patient Assistance Programs *Free Medication Programs *Discounted Medication *Discount Drug Cards *Reimbursement Programs *Glaucoma Medication Programs Since all drugs can not be listed here that patients
Patient Assistance Programs
Patient Assistance Programs *Free Medication Programs *Discounted Medication *Discount Drug Cards *Reimbursement Programs *Glaucoma Medication Programs Since all drugs can not be listed here that patients
Pharmaceutical Marketing Disclosures
Pharmaceutical Marketing Disclosures July 1, 2007 June 30, 2008 Report of Vermont Attorney General William H. Sorrell April 2009 Prepared by staff of the Vermont Attorney General s Office: Wendy Morgan,
Insurance and Reimbursement Resources for MDS Patients
Insurance and Reimbursement Resources for MDS Patients A Guide to Assistance Programs in the United States Third Edition the myelodysplastic syndromes foundation, inc. Published by The Myelodysplastic
Annual Press Conference 2012. Business Year 2011
Business Year 2011 Highlights of the Business Year 2011 Andreas Barner Chairman of the Board of Managing Directors Corporate Board Division Pharma Research, Development and Medicine Value through Innovation
The United States False Claims Act Qui Tam Whistleblower Law
The United States False Claims Act Qui Tam Whistleblower Law Getnick & Getnick LLP Counsellors At Law Rockefeller Center, 620 Fifth Avenue New York, NY 10020 Phone: (212) 376-5666 Fax: (212) 292 3942 www.getnicklaw.com
ehealthinsight Series: Online Patient Recruitment Strategies
A Datamonitor report ehealthinsight Series: Online Patient Recruitment Strategies Published: May-08 Product Code: Providing you with: Overview of benefits and drawbacks of online Analysis of online patient
Pharmaceutical Products Liability. Michael C. Dubin Stephen Knobloch
Pharmaceutical Products Liability Michael C. Dubin Stephen Knobloch Objectives Objective 1 Get Actuaries Thinking About Adding Value to New Areas Objective 2 Provide example using pharmaceutical industry
Complete the enrollment form on the reverse side to join Onyx 360 today.
Complete the enrollment form on the reverse side to join Onyx 360 today. Oncology Nurse Advocates are available Monday through Friday, from 9 am to 8 pm Eastern Standard Time at 1-855-ONYX-360 (1-855-669-9360)
Make sure you re covered for your biologic medicine!
It s open enrollment time Make sure you re covered for your biologic medicine! Joint Decisions is brought to you by Janssen Biotech, Inc., in partnership with CreakyJoints CreakyJoints Bringing arthritis
Copyrighted material 978 1 137 00589 2
B. Rajesh Kumar 2012 All rights reserved. No reproduction, copy or transmission of this publication may be made without written permission. No portion of this publication may be reproduced, copied or transmitted
Prescription Drugs: Smart Shopping Yields Big Savings
Prescription Drugs: Smart Shopping Yields Big Savings If you re paying out-of-pocket for prescription drugs, you can save a lot of money by shopping smart. Consumers CHECKBOOK magazine has studied drug
Family Practitioners, General Practitioners, Internists, Physician Assistants, Nurse Practitioners, and Nurses
36 th Annual Family Practice Review Online Planned and produced in accordance with the ACCME essentials. RELEASE DATE: February 25, 2013 EXPIRATION DATE: February 25, 2015 Physicians $750 Non-Physicians
Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus)
A Datamonitor report Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus) Published: Oct 07 Product Code: DMTC2133 Providing you with: Identifies which technology vendors
6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality
6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality March 24-25, 2015 Wyndham Philadelphia Historic District, Philadelphia, PA www.exlevents.com/gcp Sponsors
June 28-29 Washington, DC SPONSORSHIP OPPORTUNITIES
June 28-29 Washington, DC SPONSORSHIP OPPORTUNITIES OVERVIEW Due rising out-of-pocket consumer healthcare costs, the recently passed healthcare reform legislation, and new technology innovation, the healthcare
New Treatments. For Bipolar Disorder. Po W. Wang, MD Clinical Associate Professor Bipolar Disorders Clinic Stanford University School of Medicine
New Treatments For Bipolar Disorder Po W. Wang, MD Clinical Associate Professor Bipolar Disorders Clinic Stanford University School of Medicine Abbott Laboratories AstraZeneca Bristol-Myers Squibb Corcept
KEEPING CLINICAL TRIALS IN AUSTRALIA
OCCASIONAL PAPER SERIES KEEPING CLINICAL TRIALS IN AUSTRALIA WHY ACTION IS NEEDED NOW OCCASIONAL PAPER SERIES > Medicines Australia is producing Occasional Papers to promote a contest of ideas, thought
Profile of Biomedical Research and Biotechnology Commercialization. Philadelphia Wilmington Atlantic City Consolidated Metropolitan Statistical Area
Profile of Biomedical Research and Biotechnology Commercialization Philadelphia Wilmington Atlantic City Consolidated Metropolitan Statistical Area Overview and History of Biotechnology in Metropolitan
Patient Tools: What You Need to Know about Paying for Your Osteoporosis Medications. February 2012. Developed by the National Osteoporosis Foundation
Patient Tools: about Paying for Your Osteoporosis Medications Developed by the National Osteoporosis Foundation February 2012 Paying for Your Osteoporosis Medications: What You Need to Know How much your
PATIENT APPLICATION FORM INSTRUCTIONS
INSTRUCTIONS The Safety Net Foundation is a nonprofit patient assistance program that helps qualifying uninsured patients access Amgen medicines at no cost. To apply online, access program information
SUPPORT PATH PROGRAM INTAKE FORM PHONE: 1-855-769-7284 FAX: 1-855-298-8700
SUPPORT PATH PROGRAM INTAKE FORM PHONE: 1-855-769-7284 FAX: 1-855-298-8700 1 REQUESTED SERVICE(S) (REQUIRED) CHECK ALL BOXES THAT APPLY Benefits Investigation Prior Authorization and Appeals Support Patient
Problems Facing the Pharmaceutical Industry and Approaches to Ensure Long Term Viability
University of Pennsylvania ScholarlyCommons Master of Science in Organizational Dynamics Theses Organizational Dynamics Programs 5-4-2010 Problems Facing the Pharmaceutical Industry and Approaches to Ensure
Prescription Drugs and Mass Media Advertising, 2000
N O V E M B E R 2 0 0 1 Prescription Drugs and Mass Media Advertising, 2000 A research report by The National Institute for Health Care Management Research and Educational Foundation C O N T E N T S 1225
PRESCRIPTION DRUG PROGRAMS FOR OLDER AMERICANS A STAFF REPORT SPECIAL COMMITTEE ON AGING UNITED STATES SENATE. Serial No. 102-S
102d Congress COMMITTEE PRINT T. 2d Session 102-117 PRESCRIPTION DRUG PROGRAMS FOR OLDER AMERICANS (INCLUDES A DIRECTORY OF PHARMACEUTICAL MANUFACTURER INDIGENT PATIENT PROGRAMS) A STAFF REPORT OF THE
Scott Byrne & Rachel Weeks G400: Pharma Report 10/22/09 Direct to Consumer Advertising: The Affect on the Pharmaceutical Industry
Scott Byrne & Rachel Weeks G400: Pharma Report 10/22/09 Direct to Consumer Advertising: The Affect on the Pharmaceutical Industry A Glance at the Pharmaceutical Industry The pharmaceutical industry is
Stakeholder Insight: Insulin Use in Type 2 Diabetes
A Datamonitor Report Stakeholder Insight: Insulin Use in Type 2 Diabetes From Last Resort to Early Intervention Published: May-04 Product Code: DMHC1989 Providing you with: Analysis of Datamonitor s Diabetes
The power of creativity www.originbranding.com. Pharmaceutical Branding 2012
The power of creativity www.originbranding.com Pharmaceutical Branding 2012 We are an independent, boutique agency passionately focused on developing pharmaceutical brands. For over 15 years we have delivered
Campbell Alliance. Press Kit Materials
Campbell Alliance Press Kit Materials Raleigh, N.C. Parsippany, N.J. Woodland Hills, Calif. South San Francisco Chicago New York City TABLE OF CONTENTS Document Page # About Campbell Alliance 3 Company
Pharmaceutical industry
8 th March 2016 Pharmaceutical industry 2015 Global ranking strategy decisive The annual company reporting season is always an exciting period. It is an ideal time to update our industry statistics and
GLEEVEC PATIENT ASSISTANCE PROGRAM USA Patient Guide. Joan D. Ramos, MSW Cancer Resources & Advocacy Seattle, WA
GLEEVEC PATIENT ASSISTANCE PROGRAM USA Patient Guide Joan D. Ramos, MSW Cancer Resources & Advocacy Seattle, WA This guide is for informational purposes only and does not constitute legal or medical advice.
Co-Pay Assistance Program for CUBICIN (daptomycin for injection) for Intravenous Use Enrollment Form
1. PATIENT INFORMATION Name Gender: o Male o Female Date of Birth: / / Address City State ZIP Email Home Phone Cell Phone Work Phone Alternate Contact Person (Optional) Alternate Phone Number (Optional)
These are just some of the eligibility requirements meeting these criteria does not guarantee acceptance.
BARACLUDE PATIENT ASSISTANCE PROGRAM The Baraclude Patient Assistance Program is designed to provide free medication to qualifying patients who do not have prescription drug coverage and are having a hard
www.oxfordhealth.com
www.oxfordhealth.com Oxford s HMO products are underwritten by Oxford Health Plans (NY), Inc., Oxford Health Plans (NJ), Inc., and Oxford Health Plans (CT), Inc., and insurance products are underwritten
supplement 18 PAYS D'ORIGINE NOM DOSAGE FORME NR ST LABORATOIRE 4ML CONCENTRATE FOR SOLUTION FOR INFUSION x 1VIAL
supplement 18 NOM DOSAGE FORME NR ST LABORATOIRE PAYS D'ORIGINE ACTEMRA 80MG/4ML 4ML CONCENTRATE FOR SOLUTION FOR INFUSION x 218156/09 * CHUGAI PHARMA MANUFACTURING CO LTD FOR F.HOFFMANN-LA ROCHE LTD -
Blockbuster!!! Content Management in the Pharmaceutical Industry An Overview. Global Pharma Market Shares by Sales (Approx. USD 700 Billion) Global
Content Management in the Pharmaceutical Industry An Overview Blockbuster!!! Avatar USD 2 Billion revenues Lipitor USD 12.5 Billion in 2008 Dr Arun Gangatkar http://in.linkedin.com/in/drarungangatkar [email protected]
Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015
Brochure More information from http://www.researchandmarkets.com/reports/3398017/ Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015 Description: Small-Cell Lung Cancer Global Clinical Trials
Manufacturer of drug substance
Original s and Biosimilars (marketing authorizations in the EU) Date: January 2016 1) Somatropin s ORIGINAL PRODUCTS: Authorization Genentech Genotropin Somatropin Pharmacia/ Pfizer E. coli Humatrope Somatropin
Novel Opportunities for Engagement Utilizing in House Pharmacy Services
Novel Opportunities for Engagement Utilizing in House Pharmacy Services Ray Bailey, BSPharm RPh Director of Pharmacy, FCS Rx to Go Pharmacy [email protected] Angel Aslo, Pharm.D. Director of Pharmacy,
PHARMACEUTICAL MANAGEMENT PROCEDURES
PHARMACEUTICAL MANAGEMENT PROCEDURES THE FORMULARY The purpose of Coventry Health Care s formulary is to encourage use of the most cost-effective drugs. The formulary is necessary because the cost of prescription
Coventry Health Care of Georgia, Inc. Coventry Health and Life Insurance Company
Coventry Health Care of Georgia, Inc. Coventry Health and Life Insurance Company PRESCRIPTION DRUG RIDER This Prescription Drug Rider is an attachment to the Coventry Health Care of Georgia, Inc. ( Health
Specialty Pharmacy: Understanding the Market and Solution. Your Goals. Presented by Chris Brown November 2009
Specialty Pharmacy: Understanding the Market and Solution Presented by Chris Brown November 2009 Your Goals What What is a Specialty is a specialty Medication? medication? Specialty drugs are injectable,
Statement of Conflicts of Interest
10 th Annual 340B Coalition Winter Conference Expansion of Pharmacy Services Through the 340B Program Binita Patel, PharmD, MS Director of Ambulatory/Retail Services Froedtert & Medical College of Wisconsin
Welcome to Neighborhood!
Welcome to Neighborhood! This is your Neighborhood Member Handbook. Your Member Handbook has important information about the health care benefits, programs, and services that Neighborhood can offer you.
Express Scripts/Medco Prescription Plan Information For Drug Coverage Review, Prior Authorization Process and Personalized Medicine Information
Express Scripts/Medco Prescription Plan Information For Drug Coverage Review, Prior Authorization Process and Personalized Medicine Information The endowed health plan offers faculty and staff members
The Drug Distribution Project (DDP) was created
Vol. 34, No. 5, September October 2004, pp. 353 358 issn 0092-2102 eissn 1526-551X 04 3405 0353 informs doi 10.1287/inte.1040.0095 2004 INFORMS Distributing Scarce Drugs for the Medpin Program Jayashankar
A PATIENT S GUIDE Understanding Your Healthcare Benefits
A PATIENT S GUIDE Understanding Your Healthcare Benefits This guide includes useful information about how health insurance works and the reimbursement process used to pay for treatments. TABLE OF CONTENTS
Stakeholder Insight: Rheumatoid Arthritis Biologics battle up the treatment algorithm
A Datamonitor report Stakeholder Insight: Rheumatoid Arthritis Biologics battle up the treatment algorithm Published: Sep-06 Product Code: Providing you with: Disease overview including epidemiology, physician
Pertuzumab in Trastuzumab- Treated, Advanced HER2-Positive Breast Cancer
Pertuzumab in Trastuzumab- Treated, Advanced HER2-Positive Breast Cancer For more visit ResearchToPractice.com/5MJC CME INFORMATION OVERVIEW OF ACTIVITY Each year, thousands of clinicians and basic scientists
Specialty drug program. Save time. Save money. Feel good.
Specialty drug program Save time. Save money. Feel good. What are specialty drugs? Specialty drugs are used to treat serious or ongoing medical conditions such as multiple sclerosis, hemophilia, hepatitis
Your Guide to Getting Health Insurance
Your Guide to Getting Health Insurance Getting Health Insurance: KEY QUESTIONS The following is a list of key questions and things to think about when selecting health insurance to best meet your needs
Welcome to the LILETTA Patient Savings Program
Welcome to the LILETTA Patient Savings Program Eligible insured patients, activate your card today* * See full program Terms and Conditions on page 3 of this brochure or at LILETTAcard.com. Help With Your
Rx-360 An International Pharmaceutical Supply Chain Consortium
Rx-360 An International Pharmaceutical Supply Chain Consortium Overview Rx-360 and the Audit Sharing Program September 2011 Rx-360 Members (Continuously updated list at www.rx-360.org) Manufacturers (24)
Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019
Brochure More information from http://www.researchandmarkets.com/reports/3453273/ Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Description: About non-small cell lung cancer therapeutics
Key Findings. Use this report to... The Autoimmune Market Outlook to 2013
Key Findings The global autoimmune market generated sales of $31.9bn in, an increase of 14.4% over 2006 sales. The market is forecast to grow at a CAGR of 8.1% to reach a total value of $51.0bn in 2013.
Bristol-Myers Squibb Access Support Program. What Medications does the BMS Access Support Program help with? Program Registration Steps
Oncology Reimbursement Support Phone: 1-800-861-0048 Fax: 1-888-776-2370 Bristol-Myers Squibb Access Support Program The Bristol-Myers Squibb Access Support Program is designed to help patients with reimbursement
NEW HEALTH CARE CHOICES FOR 2013. Key Resources for DuPont Medicare-Eligible Retirees and Dependents
NEW HEALTH CARE CHOICES FOR 2013 Key Resources for DuPont Medicare-Eligible Retirees and Dependents ABOUT THIS BOOKLET Please read this booklet carefully. It explains what s changing for 2013, includes
Medicare Resource Guide
Medicare Resource Guide Patient Name Dear Patient, Please take the time to read the following sections of this brochure as noted by your healthcare provider. These different components of Medicare deal
Growth in revenue from MS drugs has been driven largely by price increases over the last several years.
March 4, 2013 Ben Weintraub, PhD Are Injectable MS Drugs Finished? Market Ready for Tecfidera Companies: Biogen (BIIB) Sanofi (SNY) Teva (TEVA) Novartis (NVS) Merck Serono Bayer Schering Products: Tecfidera
In the largest and perhaps the most ambitious collaborative
FEATURES THE BIRTH OF TRANSCELERATE BIOPHARMA, INC. Revolution in Clinical Research Partnerships by Dalvir Gill and Garry Neil In the largest and perhaps the most ambitious collaborative effort ever initiated
Online Drug Information in Canada. Prepared by Michael Law, Ph.D.
Online Drug Information in Canada Prepared by Michael Law, Ph.D. January 2012 Executive Summary The Internet is fast becoming a major source of information on prescription drugs for consumers, patients
Financial Planning. Patient Education Guide to Your Kidney/Pancreas Transplant Page 18-1. For a kidney/pancreas transplant.
Patient Education Page 18-1 For a kidney/pancreas transplant Kidney and pancreas transplants are expensive. Planning your finances, both your income and insurance, will be a key part of planning for transplant.
Pharma working capital performance highly variable
April 2014 Pharma working capital performance highly variable 41 Billion in Excess Working Capital We last completed this survey in 2012. We expected that there would be a broad improvement across the
MESSA Saver Rx PRESCRIPTION DRUG RIDER BOOKLET. Good Health. Good Business. Great Schools.
MESSA Saver Rx PRESCRIPTION DRUG RIDER BOOKLET Good Health. Good Business. Great Schools. MESSA Saver Rx Prescription Drug Program The MESSA Saver Rx Prescription Drug Program is made available by a Group
A Conversation About Medicare Part A, B, C and D
Please take this moment to convert the display to Full Screen A Conversation About Medicare Part A, B, C and D www..com A Conversation About Medicare Part A, B, C and D www.healthcaremedicalpharmaceuticaldirectory.com
Introducing OneExchange.
RETIREE BENEFITS Introducing OneExchange. OneExchange provides you with plan advice and enrollment assistance to choose Medicare supplemental healthcare and prescription drug coverage that s right for
Case 1:15-cv-01120-UNA Document 1 Filed 12/03/15 Page 1 of 49 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:15-cv-01120-UNA Document 1 Filed 12/03/15 Page 1 of 49 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE UNIMED PHARMACEUTICALS, LLC, BESINS HEALTHCARE INC., and BESINS
